Local Institution

Santiago de Compostela 157706

0 studies enrolling now · 9 studies all time

What they study most

Acute Coronary Syndrome (ACS), Brain Cancer, Heart Failure, Hepatitis C, Hepatitis C Virus, Melanoma, Prostate Cancer, Rheumatoid Arthritis

Studies at this site

• An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer) — Completed
• Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate — Completed
• Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma Participants — Withdrawn before enrolling
• Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure — Completed
• Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial — Completed
• Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir — Completed
• Study of Immunotherapy to Treat Advanced Prostate Cancer — Completed
• Safety Study of Apixaban in Recent Acute Coronary Syndrome — Completed
• Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis — Completed